Cargando…
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is a lethal malignancy with metastasis, a major tumor feature that predominantly correlated with progression, but the molecules that mediated tumor metastasis remain elusive. To declare the critical regulatory genes, RNA sequencing data in LUAD patients was acquired from T...
Autores principales: | Fan, Feifei, Yin, Ruxue, Wang, Liuya, Zhao, Shunxin, Lv, Dan, Yang, Kangli, Geng, Shen, Yang, Ningning, Zhang, Xiaohong, Wang, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247369/ https://www.ncbi.nlm.nih.gov/pubmed/34234849 http://dx.doi.org/10.7150/jca.58250 |
Ejemplares similares
-
BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate
por: Huang, Xinjian, et al.
Publicado: (2023) -
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway
por: Yang, Mengdi, et al.
Publicado: (2020) -
ALDH3B1 Is an Independent Prognostic Biomarker of Lung Adenocarcinoma
por: Sun, Hongmei, et al.
Publicado: (2020) -
Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis
por: Yamashita, Naoki, et al.
Publicado: (2022) -
ALDH1 as a prognostic marker for lymph node metastasis in OSCC
por: Götz, Carolin, et al.
Publicado: (2018)